108 related articles for article (PubMed ID: 12186544)
21. Proprotein convertases in amphioxus: predicted structure and expression of proteases SPC2 and SPC3.
Oliva AA; Steiner DF; Chan SJ
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3591-5. PubMed ID: 7724604
[TBL] [Abstract][Full Text] [Related]
22. Site-directed mutagenesis and yeast two-hybrid studies of the insulin and insulin-like growth factor-1 receptors: the Src homology-2 domain-containing protein hGrb10 binds to the autophosphorylated tyrosine residues in the kinase domain of the insulin receptor.
Dong LQ; Farris S; Christal J; Liu F
Mol Endocrinol; 1997 Nov; 11(12):1757-65. PubMed ID: 9369444
[TBL] [Abstract][Full Text] [Related]
23. Hydroxyl group of insulin A19Tyr is essential for receptor binding: studies on (A19Phe)insulin.
Du X; Tang JG
Biochem Mol Biol Int; 1998 Jun; 45(2):255-60. PubMed ID: 9678246
[TBL] [Abstract][Full Text] [Related]
24. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions.
Nakagawa SH; Tager HS
Biochemistry; 1992 Mar; 31(12):3204-14. PubMed ID: 1554705
[TBL] [Abstract][Full Text] [Related]
25. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
Záková L; Barth T; Jirácek J; Barthová J; Zórad S
Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
[TBL] [Abstract][Full Text] [Related]
26. The different folding behavior of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
Guo ZY; Shen L; Feng YM
Biochemistry; 2002 Feb; 41(5):1556-67. PubMed ID: 11814349
[TBL] [Abstract][Full Text] [Related]
27. Binding of mutant insulins to a mutated insulin receptor.
Rafaeloff R; Yip CC; Goldfine ID
Biochem Biophys Res Commun; 1992 Oct; 188(1):318-22. PubMed ID: 1329746
[TBL] [Abstract][Full Text] [Related]
28. Direct determination of the insulin-insulin receptor interface using transferred cross-saturation experiments.
Nakamura T; Takahashi H; Takahashi M; Shimba N; Suzuki E; Shimada I
J Med Chem; 2010 Mar; 53(5):1917-22. PubMed ID: 20158183
[TBL] [Abstract][Full Text] [Related]
29. Contribution of the residue Glu9, Glu46, and Phe49 to the biological activity of insulin-like growth factor-1.
Chen H; Feng YM
IUBMB Life; 2001 Jan; 51(1):33-7. PubMed ID: 11419693
[TBL] [Abstract][Full Text] [Related]
30. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor.
Ward CW; Lawrence MC
Bioessays; 2009 Apr; 31(4):422-34. PubMed ID: 19274663
[TBL] [Abstract][Full Text] [Related]
31. Studies on receptor binding site of insulin: the hydrophobic B12Val can be substituted by hydrophilic thr.
Wang QQ; Feng YM; Zhang YS
Biochem Mol Biol Int; 1996 Aug; 39(6):1245-54. PubMed ID: 8876979
[TBL] [Abstract][Full Text] [Related]
32. Chiral mutagenesis of insulin's hidden receptor-binding surface: structure of an allo-isoleucine(A2) analogue.
Xu B; Hua QX; Nakagawa SH; Jia W; Chu YC; Katsoyannis PG; Weiss MA
J Mol Biol; 2002 Feb; 316(3):435-41. PubMed ID: 11866509
[TBL] [Abstract][Full Text] [Related]
33. Insulin analogs with B24 or B25 phenylalanine replaced by biphenylalanine.
Du H; Shi J; Cui D; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):133-9. PubMed ID: 18235975
[TBL] [Abstract][Full Text] [Related]
34. Non-standard insulin design: structure-activity relationships at the periphery of the insulin receptor.
Weiss MA; Wan Z; Zhao M; Chu YC; Nakagawa SH; Burke GT; Jia W; Hellmich R; Katsoyannis PG
J Mol Biol; 2002 Jan; 315(2):103-11. PubMed ID: 11779231
[TBL] [Abstract][Full Text] [Related]
35. Molecular identification of an insulin growth factor binding protein (IGFBP) and its potential role in an insulin-like peptide system of the pearl oyster, Pinctada fucata.
Zhang H; Shi Y; He M
Comp Biochem Physiol B Biochem Mol Biol; 2017 Dec; 214():27-35. PubMed ID: 28939196
[TBL] [Abstract][Full Text] [Related]
36. Mutational analysis of invariant valine B12 in insulin: implications for receptor binding.
Nakagawa SH; Tager HS; Steiner DF
Biochemistry; 2000 Dec; 39(51):15826-35. PubMed ID: 11123908
[TBL] [Abstract][Full Text] [Related]
37. Interaction between the A2 and A19 amino acid residues is of critical importance for high biological activity in insulin: [19-leucine-A]insulin.
Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1984 Sep; 23(19):4444-8. PubMed ID: 6386048
[TBL] [Abstract][Full Text] [Related]
38. Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I.
Schaffer ML; Deshayes K; Nakamura G; Sidhu S; Skelton NJ
Biochemistry; 2003 Aug; 42(31):9324-34. PubMed ID: 12899619
[TBL] [Abstract][Full Text] [Related]
39. Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama.
Wan ZL; Huang K; Xu B; Hu SQ; Wang S; Chu YC; Katsoyannis PG; Weiss MA
Biochemistry; 2005 Apr; 44(13):5000-16. PubMed ID: 15794638
[TBL] [Abstract][Full Text] [Related]
40. Interaction mechanism of insulin-like peptide 5 with relaxin family peptide receptor 4.
Hu MJ; Wei D; Shao XX; Wang JH; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2017 Apr; 619():27-34. PubMed ID: 28274616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
